Journal: International journal of cancer
Article Title: In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
doi: 10.1002/ijc.32663
Figure Lengend Snippet: In vitro elimination of EGFR+ epithelial cancer cells (ECCs) by CD32A131R-chimeric receptor (CR) and CD16158F-CR T cells is associated with EGFR overexpression. (a) EGFR expression levels in the tumor cell lines as assessed by flow cytometry. The cells were incubated with 3 μg/ml of purified anti-EGFR antibody, washed and then stained with a phycoerythrin (PE)-conjugated antimouse IgG (gray filled histograms). The cells incubated with PE-conjugated antimouse IgG were used as a negative control (light gray filled histograms). Mean fluorescence intensity (MFI) is indicated for each cell line. (b) Spearman’s correlation between EGFR expression levels (MFI) in the HCT116, A549, MDA-MB-231 and MDA-MB-468 cell lines and the ECC elimination by CD16158F-CR T cells (left panel) and CD32A131R-CR T cells (right panel) in combination with cetuximab. A regression line is shown in black. Spearman’s rank correlation coefficient (r) was 0.6316 for CD16158F-CR and 0.533 for CD32A131R-CR. This is a cumulative analysis of five experiments separately performed: 116 = HCT116, 231 = MDA-MB-231, 468 = MDA-MB-468 and 549 = A549 cells.
Article Snippet: PE-conjugated goat antimouse IgG (1012-09) was purchased by Southern Biotech (Birmingham, AL).
Techniques: In Vitro, Over Expression, Expressing, Flow Cytometry, Incubation, Purification, Staining, Negative Control, Fluorescence